(WSJ) – “If you’re carrying 15-20 extra pounds,” it says, “medications like Wegovy can help jumpstart your progress.”

For obesity doctors and researchers, this kind of messaging is problematic. The blockbuster drugs—known as GLP-1s—are increasingly marketed as lifestyle fixes to help take off some weight. But they are actually designed as lifelong treatments for chronic diseases, namely obesity and Type 2 diabetes. 

That distinction matters. (Read More)